Unlocking Bevacizumab’s Potential: rCBVmax as a Predictive Biomarker for Enhanced Survival in Glioblastoma IDH-Wildtype Patients

ABSTRACT:

SUBMITTER: Alvarez-Torres M 

PROVIDER: S-EPMC10778147 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature